Untargeted metabolomics shows lipid disruptions in MRSA, indicating potential antimicrobial applications of CLOs.
Untargeted metabolomics uncovers distinct membrane-lipid disruptions in MRSA triggered by two structurally distinct cationic lipidated oligomers (CLOs).
No takes yet. Share an insight, caveat, or question.
Mahboob et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: